These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells. Huang YT, Lai PC, Wu CC, Cheng CC, Chiu TH. Int J Oncol; 2010 Oct; 37(4):943-9. PubMed ID: 20811716 [Abstract] [Full Text] [Related]
3. Overexpression of BDNF and TrkB in human bladder cancer specimens. Lai PC, Chiu TH, Huang YT. Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119 [Abstract] [Full Text] [Related]
5. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer. Yuan Y, Ye HQ, Ren QC. Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647 [Abstract] [Full Text] [Related]
6. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma. Ozono K, Ohishi Y, Onishi H, Nakamura K, Motoshita J, Kato M, Nakanishi R, Nakamura M, Oda Y. Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655 [Abstract] [Full Text] [Related]
7. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer. Gao L, Yan P, Guo FF, Liu HJ, Zhao ZF. Neoplasma; 2018 Nov; 65(1):89-96. PubMed ID: 29322793 [Abstract] [Full Text] [Related]
8. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival. Akil H, Perraud A, Mélin C, Jauberteau MO, Mathonnet M. PLoS One; 2011 Nov; 6(9):e25097. PubMed ID: 21966426 [Abstract] [Full Text] [Related]
9. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H. Clin Cancer Res; 2011 Apr 01; 17(7):1741-52. PubMed ID: 21350004 [Abstract] [Full Text] [Related]
10. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth. Kawamura N, Kawamura K, Manabe M, Tanaka T. Endocrinology; 2010 Jul 01; 151(7):3006-14. PubMed ID: 20463055 [Abstract] [Full Text] [Related]
13. Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Okugawa Y, Tanaka K, Inoue Y, Kawamura M, Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M. Br J Cancer; 2013 Jan 15; 108(1):121-30. PubMed ID: 23175149 [Abstract] [Full Text] [Related]
14. The secreted brain-derived neurotrophic factor precursor pro-BDNF binds to TrkB and p75NTR but not to TrkA or TrkC. Fayard B, Loeffler S, Weis J, Vögelin E, Krüttgen A. J Neurosci Res; 2005 Apr 01; 80(1):18-28. PubMed ID: 15704182 [Abstract] [Full Text] [Related]
15. [Expression and significance of brain-derived neurotrophic factors and receptors in multiple myeloma]. Sun CY, Hu Y, Wu T, Wang YD, He WJ. Zhonghua Nei Ke Za Zhi; 2005 Dec 01; 44(12):906-9. PubMed ID: 16409727 [Abstract] [Full Text] [Related]
16. Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway. Cao M, Niu Q, Xiang X, Yuan C, Iqbal T, Huang Y, Tian M, Zhao Z, Li C, Zhou X. Biomolecules; 2020 Dec 08; 10(12):. PubMed ID: 33302387 [Abstract] [Full Text] [Related]